Application of advanced technology in traditional Chinese medicine for cancer therapy

被引:10
作者
Ke, Gaofeng [1 ]
Zhang, Jia [2 ]
Gao, Wufeng [2 ]
Chen, Jiayi [3 ]
Liu, Luotong [3 ]
Wang, Simiao [3 ]
Zhang, Huan [3 ]
Yan, Guojun [2 ]
机构
[1] Wenzhou Med Univ, Affiliated Wenling Hosp, Dept Rehabil Med, Wenling, Peoples R China
[2] Nanjing Univ Chinese Med, Jiangsu Prov Engn Res Ctr Tradit Chinese Med Exter, Sch Pharm, Nanjing, Peoples R China
[3] Jilin Univ, Sch Life Sci, Changchun, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
traditional Chinese medicine; nanotechnology; CRISPR; Cas9; real-time cell-based assay; flow cytometry; FLOW-CYTOMETRY; CELL-GROWTH; HOMOLOGOUS RECOMBINATION; ALTERNATIVE MEDICINE; ANALYSIS SYSTEM; APOPTOSIS; EXPRESSION; DELIVERY; COMPLEMENTARY; ENDONUCLEASE;
D O I
10.3389/fphar.2022.1038063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although cancer has seriously threatened people's health, it is also identified by the World Health Organization as a controllable, treatable and even curable chronic disease. Traditional Chinese medicine (TCM) has been extensively used to treat cancer due to its multiple targets, minimum side effects and potent therapeutic effects, and thus plays an important role in all stages of tumor therapy. With the continuous progress in cancer treatment, the overall efficacy of cancer therapy has been significantly improved, and the survival time of patients has been dramatically prolonged. In recent years, a series of advanced technologies, including nanotechnology, gene editing technology, real-time cell-based assay (RTCA) technology, and flow cytometry analysis technology, have been developed and applied to study TCM for cancer therapy, which efficiently improve the medicinal value of TCM and accelerate the research progress of TCM in cancer therapy. Therefore, the applications of these advanced technologies in TCM for cancer therapy are summarized in this review. We hope this review will provide a good guidance for TCM in cancer therapy.
引用
收藏
页数:12
相关论文
共 90 条
[21]   Recognition and maturation of effector RNAs in a CRISPR interference pathway [J].
Gesner, Emily M. ;
Schellenberg, Matthew J. ;
Garside, Erin L. ;
George, Mark M. ;
MacMillan, Andrew M. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2011, 18 (06) :688-U83
[22]   Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt/mTOR suppression [J].
Gong, Xuelian ;
Jiang, Ling ;
Li, Wei ;
Liang, Qingbin ;
Li, Zhen .
BIOENGINEERED, 2021, 12 (01) :5017-5027
[23]   Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9 [J].
Gupta, Rajat M. ;
Musunuru, Kiran .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) :4154-4161
[24]   Glutamine and cancer: cell biology, physiology, and clinical opportunities [J].
Hensley, Christopher T. ;
Wasti, Ajla T. ;
DeBerardinis, Ralph J. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09) :3678-3684
[25]   Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo [J].
Hsu, Ya-Ling ;
Kuo, Po-Lin ;
Tzeng, Tz-Fei ;
Sung, Shu-Chiao ;
Yen, Ming-Hong ;
Lin, Liang-Tzung ;
Lin, Chun-Ching .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (07) :E290-E299
[26]   Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma [J].
Hu, Yangyang ;
Wang, Shengpeng ;
Wu, Xu ;
Zhang, Jinming ;
Chen, Ruie ;
Chen, Meiwan ;
Wang, Yitao .
JOURNAL OF ETHNOPHARMACOLOGY, 2013, 149 (03) :601-612
[27]   Enhanced Tumor Targeting and Radiotherapy by Quercetin Loaded Biomimetic Nanoparticles [J].
Huang, Chunyu ;
Chen, Tongkai ;
Zhu, Daoming ;
Huang, Qinqin .
FRONTIERS IN CHEMISTRY, 2020, 8
[28]  
Huang P.C., 1999, CANC RES PREVE 3, V05, P330, DOI [10.3971/j.issn.1000-8578.1999.05.004, DOI 10.3971/J.ISSN.1000-8578.1999.05.004]
[29]   Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli [J].
Jackson, Ryan N. ;
Golden, Sarah M. ;
van Erp, Paul B. G. ;
Carter, Joshua ;
Westra, Edze R. ;
Brouns, Stan J. J. ;
van der Oost, John ;
Terwilliger, Thomas C. ;
Read, Randy J. ;
Wiedenheft, Blake .
SCIENCE, 2014, 345 (6203) :1473-1479
[30]  
Jani IV, 2001, J IMMUNOL METHODS, V257, P145